211 related articles for article (PubMed ID: 17979648)
1. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation.
Kaur K; Jain S; Sapra B; Tiwary AK
Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648
[TBL] [Abstract][Full Text] [Related]
2. Studies in topical application of niosomally entrapped Nimesulide.
Shahiwala A; Misra A
J Pharm Pharm Sci; 2002; 5(3):220-5. PubMed ID: 12553889
[TBL] [Abstract][Full Text] [Related]
3. Topical Nano-Vesicular Spanlastics of Celecoxib: Enhanced Anti-Inflammatory Effect and Down-Regulation of TNF-α, NF-кB and COX-2 in Complete Freund's Adjuvant-Induced Arthritis Model in Rats.
Alaaeldin E; Abou-Taleb HA; Mohamad SA; Elrehany M; Gaber SS; Mansour HF
Int J Nanomedicine; 2021; 16():133-145. PubMed ID: 33447032
[TBL] [Abstract][Full Text] [Related]
4. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
5. Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery.
Jain SK; Gupta Y; Jain A; Bhola M
Drug Deliv; 2007 Aug; 14(6):327-35. PubMed ID: 17701522
[TBL] [Abstract][Full Text] [Related]
6. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.
Shamsher AA; Charoo NA; Rahman Z; Pillai KK; Kohli K
Pharm Dev Technol; 2014 Feb; 19(1):21-30. PubMed ID: 23281713
[TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of meloxicam niosomes as vesicular carriers for enhanced skin delivery.
El-Menshawe SF; Hussein AK
Pharm Dev Technol; 2013; 18(4):779-86. PubMed ID: 21913880
[TBL] [Abstract][Full Text] [Related]
8. Liposomal gels for site-specific, sustained delivery of celecoxib: in vitro and in vivo evaluation.
Fetih G; Fathalla D; El-Badry M
Drug Dev Res; 2014 Jun; 75(4):257-66. PubMed ID: 24939834
[TBL] [Abstract][Full Text] [Related]
9. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
[TBL] [Abstract][Full Text] [Related]
10. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
Patel KK; Kumar P; Thakkar HP
AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
[TBL] [Abstract][Full Text] [Related]
11. Diacerein niosomal gel for topical delivery: development, in vitro and in vivo assessment.
El-Say KM; Abd-Allah FI; Lila AE; Hassan Ael-S; Kassem AE
J Liposome Res; 2016; 26(1):57-68. PubMed ID: 25853339
[TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of transdermal patches of celecoxib.
Alam MI; Baboota S; Kohli K; Ali J; Ahuja A
PDA J Pharm Sci Technol; 2009; 63(5):429-37. PubMed ID: 20158049
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of extemporaneously manufactured topical gels containing aceclofenac on inflammation and hyperalgesia in rats.
Pabreja K; Dua K; Padi SS
Curr Drug Deliv; 2010 Oct; 7(4):324-8. PubMed ID: 20695843
[TBL] [Abstract][Full Text] [Related]
15. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
[TBL] [Abstract][Full Text] [Related]
16. Enhanced retention of celecoxib-loaded solid lipid nanoparticles after intra-articular administration.
Thakkar H; Kumar Sharma R; Murthy RS
Drugs R D; 2007; 8(5):275-85. PubMed ID: 17767393
[TBL] [Abstract][Full Text] [Related]
17. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion.
Subramanian N; Ghosal SK; Moulik SP
Drug Dev Ind Pharm; 2005 May; 31(4-5):405-16. PubMed ID: 16093206
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam.
Khurana S; Jain NK; Bedi PM
Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071
[TBL] [Abstract][Full Text] [Related]
19. Three levels face centered central composite design of colon targeted micro-particulates system of celecoxib: screening of formulations variables and in vivo studies.
Nandy BC; Verma V; Dey S; Mazumder B
Curr Drug Deliv; 2014; 11(5):621-35. PubMed ID: 24844925
[TBL] [Abstract][Full Text] [Related]
20. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
